Lidocaine (Orexa)

利多卡因 (Orexa)

Report date: 2024/02/23 17:18:11

Base Information

Drug NameLidocaine (Orexa)
Drug Alias NameORE-001 (Orexa)ORE001 (Orexa)
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsIleus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrexa BV
China Registration ClassN/A

Develop Information

Active CompaniesOrexa BV
Inactive CompaniesN/A
Active IndicationsIleus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A